Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3523873011 | Product containing antazoline and xylometazoline (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3713237012 | Antazoline- and xylometazoline-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing antazoline and xylometazoline (medicinal product) | Is a | Product containing xylometazoline (medicinal product) | true | Inferred relationship | Some | ||
| Product containing antazoline and xylometazoline (medicinal product) | Is a | Product containing antazoline (medicinal product) | true | Inferred relationship | Some | ||
| Product containing antazoline and xylometazoline (medicinal product) | Has active ingredient | Xylometazoline hydrochloride | false | Inferred relationship | Some | ||
| Product containing antazoline and xylometazoline (medicinal product) | Has active ingredient | Antazoline (substance) | true | Inferred relationship | Some | 2 | |
| Product containing antazoline and xylometazoline (medicinal product) | Is a | Product containing xylometazoline in ophthalmic dosage form | false | Inferred relationship | Some | ||
| Product containing antazoline and xylometazoline (medicinal product) | Has manufactured dose form | Ocular dose form (dose form) | false | Inferred relationship | Some | ||
| Product containing antazoline and xylometazoline (medicinal product) | Has active ingredient | Xylometazoline (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Is a | False | Product containing antazoline and xylometazoline (medicinal product) | Inferred relationship | Some | |
| Antazoline- and xylometazoline-containing product in ocular dose form | Is a | True | Product containing antazoline and xylometazoline (medicinal product) | Inferred relationship | Some | |
| Product containing only antazoline and xylometazoline (medicinal product) | Is a | True | Product containing antazoline and xylometazoline (medicinal product) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR